Cargando…
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
Dendritic cells (DCs) have a key role in regulating tumor immunity, tumor cell growth and drug resistance. We hypothesized that multiple myeloma (MM) cells might recruit and reprogram DCs to a tumor-permissive phenotype by changes within their microRNA (miRNA) network. By analyzing six different miR...
Autores principales: | Botta, C, Cucè, M, Pitari, M R, Caracciolo, D, Gullà, A, Morelli, E, Riillo, C, Biamonte, L, Gallo Cantafio, M E, Prabhala, R, Mignogna, C, Di Vito, A, Altomare, E, Amodio, N, Di Martino, M T, Correale, P, Rossi, M, Giordano, A, Munshi, N C, Tagliaferri, P, Tassone, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886056/ https://www.ncbi.nlm.nih.gov/pubmed/29158557 http://dx.doi.org/10.1038/leu.2017.336 |
Ejemplares similares
-
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
por: Morelli, E, et al.
Publicado: (2015) -
In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells
por: Di Martino, Maria Teresa, et al.
Publicado: (2014) -
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
por: Botta, C, et al.
Publicado: (2016) -
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
por: Pitari, Maria Rita, et al.
Publicado: (2015) -
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
por: Tagliaferri, P, et al.
Publicado: (2012)